Journal of Biomaterials and Tissue Engineering,
Год журнала:
2024,
Номер
14(3), С. 115 - 129
Опубликована: Март 1, 2024
The
respiratory
system
plays
a
crucial
role
in
human
life
activities,
and
acute
lung
injury
(ALI)
is
highly
fatal
disease
caused
by
variety
of
reasons.
At
present,
although
several
preclinical
studies
have
demonstrated
the
efficacy
pharmacological
interventions,
supportive
care
mechanical
ventilation
still
remain
primary
modalities
for
managing
ALI,
there
are
no
safe
effective
treatments
ALI.
With
rapid
development
nanotechnology,
nanobiomedicines
with
different
structures
functional
moieties
been
well-designed
based
on
their
targeting
ability
pathophysiology
In
this
review,
it
summarizes
challenges
faced
ALI
therapy,
introduces
including
liposomes,
polymers,
inorganic
materials,
others
to
bring
therapeutic
effects
discusses
research
progress
recent
years
nanobiomedicine
applied
injury.
Finally,
provides
summary
prospect
application
Pharmaceuticals,
Год журнала:
2023,
Номер
16(7), С. 924 - 924
Опубликована: Июнь 25, 2023
Prolonged,
low-dose
glucocorticoids
(GCs)
have
shown
the
highest
efficacy
among
pharmacological
and
non-pharmacological
treatments
for
COVID-19.
Despite
World
Health
Organization’s
recommendation
against
their
use
at
beginning
of
pandemic,
GCs
a
dose
equivalent
to
dexamethasone
6
mg/day
10
days
are
now
indicated
in
all
COVID-19
cases
who
require
respiratory
support.
However,
intervention
depends
on
timing
initiation,
dose,
other
individual
factors.
Indeed,
patients
treated
with
similar
GC
protocols
often
experience
different
outcomes,
which
do
not
always
correlate
presence
comorbidities
or
severity
involvement
baseline.
This
prompted
us
critically
review
literature
rationale,
principles,
clinical
evidence
that
should
guide
treatment.
Based
these
data,
best
treatment
protocol
probably
involves
an
initial
bolus
saturate
glucocorticoid
receptors,
followed
by
continuous
infusion
maintain
constant
plasma
levels,
eventually
slow
tapering
interruption.
Methylprednisolone
has
molecules,
most
likely
thanks
its
higher
ability
penetrate
lung.
Decreased
tissue
sensitivity
is
thought
be
main
mechanism
accounting
lower
response
some
individuals.
We
readily
available
test
identify
resistance;
therefore,
address
inter-individual
variability,
future
research
aim
investigating
clinical,
physiological,
laboratory
markers
personalized
approach.
Diagnostics,
Год журнала:
2023,
Номер
13(8), С. 1398 - 1398
Опубликована: Апрель 12, 2023
Coronavirus
disease-19
(COVID-19),
caused
by
SARS-CoV-2,
is
a
systemic
disease
that
affects
not
only
the
respiratory
system,
but
also
other
systems,
including
gastrointestinal.
A
great
number
of
different
drugs
have
been
used
on
hospitalized
patients
for
management
COVID-19,
and
acute
pancreatitis
(AP)
has
reported
as
complication
or
side
effect
these
drugs.
The
development
drug-induced
(DIAP)
follows
complex
pathophysiological
mechanisms,
particular
risk
factors
play
key
role.
Diagnosis
DIAP
depends
specific
criteria,
based
these,
drug
may
be
characterized
having
definite,
probable
possible
connection
with
AP.
aim
this
review
to
present
medications
are
COVID-19
associated
AP
in
patients.
list
mainly
includes
corticosteroids,
glucocorticoids,
non-steroidal
anti-inflammatory
(NSAIDs),
antiviral
agents,
antibiotics,
monoclonal
antibodies,
estrogens
anesthetic
agents.
Moreover,
prevention
vital,
especially
critically
ill
who
receive
multiple
non-invasive
first
step
concerns
exception
suspicious
from
therapy.
Science Translational Medicine,
Год журнала:
2024,
Номер
16(767)
Опубликована: Окт. 2, 2024
Acute
kidney
injury
(AKI)
is
a
frequent
and
challenging
clinical
condition
associated
with
high
morbidity
mortality
represents
common
complication
in
critically
ill
patients
COVID-19.
In
AKI,
renal
tubular
epithelial
cells
(TECs)
are
primary
site
of
damage,
recovery
from
AKI
depends
on
TEC
plasticity.
However,
the
molecular
mechanisms
underlying
adaptation
maladaptation
TECs
remain
largely
unclear.
Here,
our
study
an
autopsy
cohort
COVID-19
provided
evidence
that
by
myoglobin,
released
as
consequence
rhabdomyolysis,
major
pathophysiological
mechanism
for
severe
Analyses
human
biopsies,
mouse
models
myoglobinuric
gentamicin-induced
tubuloids
showed
resulted
activation
glucocorticoid
receptor
endogenous
glucocorticoids,
which
aggravated
damage.
The
detrimental
effect
glucocorticoids
injured
was
exacerbated
administration
widely
clinically
used
synthetic
glucocorticoid,
dexamethasone,
indicated
experiments
myoglobinuric-
folic
acid–induced
tubuloids,
slice
cultures.
Mechanistically,
studies
cultures
demonstrated
signaling
orchestrated
maladaptive
transcriptional
program
to
hinder
DNA
repair,
amplify
injury-induced
double-strand
break
formation,
dampen
mTOR
activity
mitochondrial
bioenergetics.
This
identifies
maladaptation,
functionally
important
AKI.
ACR Open Rheumatology,
Год журнала:
2023,
Номер
5(12), С. 685 - 693
Опубликована: Окт. 11, 2023
We
estimated
the
association
between
immunosuppressive
and
immunomodulatory
agent
(IIA)
exposure
severe
COVID-19
outcomes
in
a
population-based
cohort
study.Participants
were
18
years
or
older,
tested
positive
for
SARS-CoV-2
February
6,
2020,
August
15,
2021,
from
administrative
health
data
entire
province
of
British
Columbia,
Canada.
IIA
use
within
3
months
prior
to
test
included
conventional
disease-modifying
antirheumatic
drugs
(antimalarials,
methotrexate,
leflunomide,
sulfasalazine,
individually),
immunosuppressants
(azathioprine,
mycophenolate
mofetil/mycophenolate
sodium
[MMF],
cyclophosphamide,
cyclosporine,
individually
collectively),
tumor
necrosis
factor
inhibitor
(TNFi)
biologics
(adalimumab,
certolizumab,
etanercept,
golimumab,
infliximab,
non-TNFi
targeted
synthetic
(tsDMARDs)
(rituximab
separately
abatacept,
anakinra,
secukinumab,
tocilizumab,
tofacitinib
ustekinumab
glucocorticoids.
Severe
hospitalizations
COVID-19,
ICU
admissions,
deaths
60
days
test.
Exposure
score-overlap
weighting
was
used
balance
baseline
characteristics
participants
with
compared
nonuse
that
IIA.
Logistic
regression
measured
outcomes.From
147,301
participants,
we
identified
515
antimalarial,
573
72
180
468
immunosuppressant,
378
TNFi
biologic,
49
rituximab,
144
other
biologic
tsDMARD,
1348
glucocorticoid
prescriptions.
Risk
significantly
greater
MMF
(odds
ratio
[95%
CI]):
2.82
[1.81-4.40],
all
immunosuppressants:
2.08
[1.51-2.87],
glucocorticoids:
1.63
[1.36-1.96],
relative
nonuse.
Similar
seen
admission
MMF:
2.52
[1.34-4.74],
2.88
[1.73-4.78],
1.86
[1.37-2.54].
Only
glucocorticoids
associated
significant
increase
60-day
mortality:
1.58
[1.21-2.06].
No
IIAs
displayed
statistically
associations
outcomes.Current
an
increased
risk
These
results
emphasize
variety
circumstances
patients
taking
IIAs.
Neonatal
cytokine
storms,
though
rare,
can
induce
hyperinflammation
due
to
elevated
interleukin-6
(IL-6),
triggering
multiorgan
failure.
We
present
the
case
of
a
term
male
neonate
necessitating
extracorporeal
membrane
oxygenation
(ECMO)
post-birth
for
persistent
pulmonary
hypertension
meconium
aspiration
syndrome.
Three
days
after
weaning
from
ECMO
support,
steroids
and
therapeutic
plasma
exchange
were
initiated
deteriorating
thrombocytopenia,
oxygenation,
hemodynamic
instability,
increased
C-reactive
protein
(CRP)
ferritin
levels.
Elevated
IL-6
prompted
tocilizumab
administration
four
daily
plasmapheresis.
Post-tocilizumab
infusion,
notable
enhancements
in
platelet
counts,
indices,
CRP
observed,
resulting
stable
discharge
child.
Comprehensive
evaluations
infections,
including
coronavirus
disease
2019,
as
well
genetic
metabolic
disorders,
yielded
negative
results.
bioRxiv (Cold Spring Harbor Laboratory),
Год журнала:
2023,
Номер
unknown
Опубликована: Дек. 25, 2023
Abstract
Cis-regulatory
elements
(CREs)
control
gene
transcription
dynamics
across
cell
types
and
in
response
to
the
environment.
In
asthma,
multiple
immune
play
an
important
role
inflammatory
process.
Genetic
variants
CREs
can
also
affect
expression
contribute
asthma
risk.
However,
regulatory
mechanisms
underlying
of
transcriptional
different
environmental
contexts
cell-types
at
single
resolution
remains
be
elucidated.
To
resolve
this
question,
we
performed
scATAC-seq
activated
peripheral
blood
mononuclear
cells
(PBMC)
from
16
children
with
phytohemagglutinin
(PHA)
or
lipopolysaccharide
(LPS),
treated
dexamethasone
(DEX),
antiinflammatory
glucocorticoid.
We
analyzed
changes
chromatin
accessibility,
measured
factor
motif
activity,
identified
treatment
cell-type
specific
factors
that
drive
both
mean
variability.
observed
strong
positive
linear
dependence
between
their
target
changes,
but
negative
variability
changes.
This
result
suggests
increase
binding
tightens
around
mean.
then
annotated
genetic
accessibility
peaks
motifs
followed
by
computational
fine-mapping
eQTL
signals
a
pediatric
cohort.
found
eQTLs
were
5-fold
enriched
refined
credible
set
for
410
risk
genes,
191
having
causal
variant
motifs.
conclusion,
enhances
understanding
molecular
mediated
expression.
Reports — Medical Cases Images and Videos,
Год журнала:
2024,
Номер
7(2), С. 25 - 25
Опубликована: Апрель 5, 2024
A
rise
in
fungal
infections
has
been
observed
worldwide
among
patients
with
extended
hospital
stays
because
of
the
severe
infection
caused
by
new
coronavirus
pandemic.
62-year-old
female
patient
was
admitted
a
form
Coronavirus
disease
2019
(COVID-19)
and
spent
four
weeks
intensive
care
unit
(ICU)
requiring
mechanical
ventilation
support
before
being
moved
to
tertiary
for
further
testing.
Aspergillus
fumigatus
filamentous
fungus,
Candida
spp.,
positive
bacteriology
multidrug-resistant
Klebsiella
pneumoniae
Proteus
mirabilis
were
identified
bronchial
aspirate
cultures.
The
patient’s
progress
gradually
encouraging
while
receiving
oral
antifungal
broad-spectrum
antibiotic
therapy
along
respiratory
physical
therapy;
but
ultimately,
thoracic
surgery
necessary.
Long-lasting
tissue
damage
severe,
persistent
inflammatory
syndrome
two
main
pathophysiological
mechanisms
that
led
significant
outcomes
regarding
lung
lesions
rapidly
colonized
fungi
resistant
flora,
cardiac
sinus
tachycardia
at
slightest
effort,
chronic
syndrome,
which
characterized
marked
asthenia,
myalgias,
exercise
intolerance.